rumor
    rumor
    • Screeners
    • Heatmaps
    • Charts
    • News
    • Documentation
    • Pricing
    • FAQ
    You're viewing limited data.
    Log inSign up

    Sign up

    24 hours of full access, free. No credit card.

    Log inPricing
    1 asset

    Market news

    TypeAll
    SortNewest
    Assets
    CAI
    Type
    TypeAll
    All
    Sort
    SortNewest
    Newest

    Filter by asset

      Why is Caris Life Sciences stock rallying today?
      Nov 17Investing.comCAI
      Caris Life Sciences Presented Research Demonstrating the Value of Whole Transcriptome Sequencing in Precision Oncology at the Association of Molecular Pathology 2026 Annual Meeting
      Nov 16Yahoo FinanceCAI
      Caris Life Sciences Publishes Study Highlighting the Value of Comprehensive Molecular Profiling in Characterizing ESR1-Mutated Metastatic Breast Cancer
      Nov 9Yahoo FinanceCAI
      Caris Life Sciences Inc (CAI) Q3 2026 Earnings Call Highlights: Record Revenue, Sixth Straight ...

      Caris Life Sciences Inc (CAI) posted 27% revenue growth to a record $275.4 million, returned to GAAP profitability, and lifted its 2026 revenue outlook to roughly $1.04 billion to $1.05 billion.

      Nov 7Yahoo FinanceCAI
      Caris Life Sciences stock falls after hours despite Q3 beat, BTIG maintains buy
      Nov 5Investing.comCAI
      TD Cowen raises Caris Life Sciences stock price target on pipeline
      Nov 5Investing.comCAI
      14% Below Fair Value? Caris Life Sciences (CAI) On Raised 2026 Guidance

      Caris Life Sciences (CAI) has drawn fresh attention after reporting third quarter 2026 earnings, with revenue of US$275.36 million and earnings of US$0.05 per share, alongside a higher full year revenue outlook. At a share price of US$33.22, Caris Life Sciences has posted a 30 day share price return of 21% and a 90 day share price return of 46.09%. The 1 year total shareholder return of 34.99% points to momentum that has been building rather than fading over time. Spot similar momentum and...

      Nov 5Yahoo FinanceCAI
      Caris Life Sciences Q3 2026 Earnings Call Transcript
      Nov 4BenzingaCAI
      Caris Life Sciences,?Inc. (CAI) Q3 Earnings and Revenues Top Estimates
      Nov 4Yahoo FinanceCAI
      Caris Life Sciences earnings on deck: Can profitability rebound?
      Nov 4Investing.comCAI
      Analysts Estimate Caris Life Sciences,?Inc. (CAI) to Report a Decline in Earnings: What to Look Out for
      Oct 28Yahoo FinanceCAI
      Caris Life Sciences Launches New National Commercial Featuring Jordan Spieth Highlighting the Power of Artificial Intelligence in Early Stage Cancer Detection
      Oct 19MorningstarCAI
      Caris Life Sciences to Report Third Quarter 2026 Financial Results on November 4, 2026
      Oct 15Yahoo FinanceCAI
      Caris Life Sciences to Present Eight Studies Highlighting the Power of AI, Multi-Omics and Precision Medicine at ESMO 2026
      Oct 14MorningstarCAI
      SEC Charges California Investment Advisor in Alleged Cherry-Picking Scheme
      Oct 9Barron'sCAI
      IPO Stock Of The Week: Caris Pulls Back After More Than Doubling In Just Two Months

      Caris stock is taking a breather after charging higher over just two months. Wait for the IPO stock to offer a new buy point.

      Oct 2Investor's Business DailyCAI
      Caris Life Sciences SVP Denton sells $238,626 in shares
      Sep 24Investing.comCAI
      Caris Life Sciences Coasts Past A Buy Point; Why This Texas Biotech Researcher Deserves A Look

      Caris Life Sciences has surged off its May low near 14. The molecular research firm for drug companies might turn profitable this year.

      Sep 22Investor's Business DailyCAI
      Caris Life Sciences: Adjusting My Position After A Recent Steep Incline (Downgrade)
      Sep 22Seeking AlphaCAI
      Caris Life Sciences Stock Jumped 10% Yesterday. Here’s Where Shares Could Go Further in 2026.

      Key TakeawaysSector Rally: Caris Life Sciences (CAI) stock jumped 9. 61% to close at $31 on Thursday, September 17, riding a Fed-driven market rally and a surge across AI-powered precision oncology peers.

      Sep 18Yahoo FinanceCAI
      Caris Life Sciences vice chairman Brille sells $12.1 million shares
      Sep 17Investing.comCAI
      Caris Life Sciences: Diagnostics Growth With Room To Run (NASDAQ:CAI)
      Sep 17Seeking AlphaCAI
      Caris Life Sciences, Inc. (CAI) Soars 9.4%: Is Further Upside Left in the Stock?

      Caris Life Sciences, Inc. (CAI) was a big mover last session on higher-than-average trading volume. The latest trend in earnings estimate revisions might not help the stock continue moving higher in the near term.

      Sep 16Yahoo FinanceCAI
      UBS Initiates Coverage on Caris Life Sciences With Neutral Rating, $28 Price Target

      Caris Life Sciences, Inc. (CAI) has an average rating of overweight and mean price target of $27.08,

      Sep 9Yahoo FinanceCAI
      Could Caris Life Sciences (CAI) Be 7% Undervalued After Its Lung Cancer Research Update?

      Caris Life Sciences (CAI) is drawing fresh attention after announcing that its researchers will present seven lung cancer studies at the 2026 World Conference on Lung Cancer in Seoul this month. For investors, the World Conference presentations and August’s pancreatic cancer AI publication land against a mixed share price backdrop for Caris Life Sciences, with the stock down 28.06% on a 1 year total shareholder return basis but showing strong 90 day share price momentum of 55.33% and a 30 day...

      Sep 6Yahoo FinanceCAI
      Caris Life Sciences (CAI) Will Present Seven Studies At A Global Lung Conference

      Caris Life Sciences (NasdaqGS: CAI) announced plans to present seven major precision oncology studies at the IASLC 2026 World Conference on Lung Cancer. The company highlighted new data on molecular profiling and AI powered analysis for lung cancer care. Caris also published a validated AI driven method designed to help optimize first line pancreatic cancer treatment choices. For readers following how AI is reshaping cancer research and treatment, it can also be useful to look at other...

      Sep 5Yahoo FinanceCAI
      President Spetzler sells $14.8m in Caris Life Sciences stock
      Sep 4Investing.comCAI
      Caris Life Sciences to Present New Research Advancing Precision Oncology at the IASLC 2026 World Conference on Lung Cancer
      Sep 2MorningstarCAI
      Caris publishes study on AI tool for pancreatic cancer treatment
      Aug 27Investing.comCAI
      Caris Life Sciences Publishes npj Precision Oncology Study Showing AI-Guided Therapy Selection is Predictive of Longer Survival in Patients with Pancreatic Cancer
      Aug 27MorningstarCAI

      This is the newest page. Registered accounts read further back.